Shabsovich David, Kathuria-Prakash Nikhita, Zhang Jiajia, Cabral Marsenne, Lopez Lidia, Sumal Amit, Drakaki Alexandra
Internal Medicine, University of California Los Angeles, Los Angeles, USA.
Hematology-Oncology, University of California Los Angeles, Los Angeles, USA.
Cureus. 2025 Jun 8;17(6):e85573. doi: 10.7759/cureus.85573. eCollection 2025 Jun.
Adrenal insufficiency is a known complication of both immune checkpoint inhibitors (ICIs) and resection or ablation of the adrenal glands. In the modern era of immunotherapy, more frequent assessment of the adrenal hormonal axis is performed after initiation of ICIs in order to monitor for such complications. The interpretation of these laboratory tests, such as elevated adrenocorticotropic hormone (ACTH), in patients who receive ICIs and undergo adrenalectomy or adrenal ablation provides an additional set of diagnostic challenges that are not well described. We present a case series of four patients who had elevated ACTH without clinical (symptoms) or biochemical (decreased cortisol) evidence of adrenal insufficiency, a pattern suggesting a compensatory increase in ACTH. This highlights an emerging phenomenon and diagnostic challenge in the monitoring of the adrenal axis in patients undergoing adrenalectomy or ablation alongside ICI therapy, emphasizing the need for close follow-up and thorough investigation to rule out adrenal insufficiency in such patients.
肾上腺功能不全是免疫检查点抑制剂(ICI)以及肾上腺切除或消融术已知的并发症。在免疫治疗的现代时代,ICI治疗开始后会更频繁地评估肾上腺激素轴,以监测此类并发症。对于接受ICI治疗并接受肾上腺切除术或肾上腺消融术的患者,对这些实验室检查结果(如促肾上腺皮质激素(ACTH)升高)的解读带来了一系列额外的诊断挑战,目前对此尚无充分描述。我们报告了一组4例患者的病例系列,这些患者的ACTH升高,但无肾上腺功能不全的临床(症状)或生化(皮质醇降低)证据,这种模式提示ACTH的代偿性增加。这凸显了在接受肾上腺切除术或消融术并同时接受ICI治疗的患者中监测肾上腺轴时出现的一种新现象和诊断挑战,强调对此类患者需要密切随访并进行全面检查以排除肾上腺功能不全。